Efficacy of 3T Multiparametric MR Imaging followed by 3T in-Bore MR-Guided Biopsy for Detection of Clinically Significant Prostate Cancer Based on PIRADSv2.1 Score

Mottet, 2017, EAU-ESTRO-SIOG guidelines on prostate cancer. part 1: screening, diagnosis, and local treatment with curative intent, Eur Urol, 71, 618, 10.1016/j.eururo.2016.08.003 Wilt, 2017, Follow-up of prostatectomy versus observation for early prostate cancer, N Engl J Med, 377, 132, 10.1056/NEJMoa1615869 Hamdy, 2016, 10-Year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer, N Engl J Med, 375, 1415, 10.1056/NEJMoa1606220 Felker, 2016, In-bore magnetic resonance-guided transrectal biopsy for the detection of clinically significant prostate cancer, Abdom Radiol (NY), 41, 954, 10.1007/s00261-016-0750-7 Turkbey, 2016, Multiparametric prostate magnetic resonance imaging in the evaluation of prostate cancer, CA Cancer J Clin, 66, 326, 10.3322/caac.21333 Padhani, 2019, Prostate imaging-reporting and data system steering committee: PI-RADS v2 status update and future directions, Eur Urol, 75, 385, 10.1016/j.eururo.2018.05.035 Woo, 2017, Diagnostic performance of prostate imaging reporting and data system version 2 for detection of prostate cancer: a systematic review and diagnostic meta-analysis, Eur Urol, 72, 177, 10.1016/j.eururo.2017.01.042 Ahmed, 2017, Diagnostic accuracy of multiparametric MRI and TRUS biopsy results in prostate cancer (PROMIS): a paired validating confirmatory study, Lancet, 389, 815, 10.1016/S0140-6736(16)32401-1 Kasivisvanathan, 2018, MRI-targeted or standard biopsy for prostate-cancer diagnosis, N Engl J Med, 378, 1767, 10.1056/NEJMoa1801993 Panebianco, 2015, Multiparametric magnetic resonance imaging vs. standard care in men being evaluated for prostate cancer: a randomized study, Urol Oncol, 33, 17 e1, 10.1016/j.urolonc.2014.09.013 Kaufmann, 2015, Direct comparison of targeted MRI-guided biopsy with systematic transrectal ultrasound-guided biopsy in patients with previous negative prostate biopsies, Urol Oncol, 94, 319 Hambrock, 2010, Magnetic resonance imaging guided prostate biopsy in men with repeat negative biopsies and increased prostate specific antigen, J Urol, 183, 520 Schoots, 2015, Magnetic resonance imaging-targeted biopsy may enhance the diagnostic accuracy of significant prostate cancer detection compared to standard transrectal ultrasound-guided biopsy: a systematic review and meta-analysis, Eur Urol, 68, 438, 10.1016/j.eururo.2014.11.037 Venderink, 2019, Multiparametric MRI and follow-up to avoid prostate biopsy in 4259 men, BJU Int, 10.1111/bju.14853 van der Leest, 2019, Eur Urol, 75, 570, 10.1016/j.eururo.2018.11.023 Moore, 2013, Standards of reporting for MRI-targeted biopsy studies (START) of the prostate: recommendations from an international working group, Eur Urol, 64, 544, 10.1016/j.eururo.2013.03.030 Barentsz, 2016, Synopsis of the PI-RADS v2 guidelines for multiparametric prostate magnetic resonance imaging and recommendations for use, Eur Urol, 69, 41, 10.1016/j.eururo.2015.08.038 Barentsz, 2012, ESUR prostate MR guidelines 2012, Eur Radiol, 22, 746, 10.1007/s00330-011-2377-y Tan, 2017, In-bore 3T MR-guided transrectal targeted prostate biopsy: prostate imaging reporting and data system version 2-based diagnostic performance for detection of prostate cancer, Radiology, 283, 130, 10.1148/radiol.2016152827 Wegelin, 2019, The FUTURE trial: a multicenter randomised controlled trial on target biopsy techniques based on magnetic resonance imaging in the diagnosis of prostate cancer in patients with prior negative biopsies, Eur Urol, 75, 582, 10.1016/j.eururo.2018.11.040 Siddiqui, 2015, Comparison of MR/ultrasound fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer, JAMA, 313, 390, 10.1001/jama.2014.17942 Lavaerts, 2016, TRUS-MR fusion biopsy of the prostate: radiological and histological correlation, J Belg Soc Radiol, 100, 109, 10.5334/jbr-btr.1199 Volkin, 2014, Multiparametric magnetic resonance imaging (MRI) and subsequent MRI/ultrasonography fusion-guided biopsy increase the detection of anteriorly located prostate cancers, BJU Int, 114, E43, 10.1111/bju.12670 Mendhiratta, 2015, Magnetic resonance imaging-ultrasound fusion targeted prostate biopsy in a consecutive cohort of men with no previous biopsy: reduction of over detection through improved risk stratification, J Urol, 194, 1601 Miah, 2019, A multicentre analysis of the detection of clinically significant prostate cancer following transperineal image-fusion targeted and nontargeted systematic prostate biopsy in men at risk, Eur Urol Oncol Venderink, 2017, Results of targeted biopsy in men with magnetic resonance imaging lesions classified equivocal, likely or highly likely to be clinically significant prostate cancer, Eur Urol Rouviere, 2019, Use of prostate systematic and targeted biopsy on the basis of multiparametric MRI in biopsy-naive patients (MRI-FIRST): a prospective, multicentre, paired diagnostic study, Lancet Oncol, 20, 100, 10.1016/S1470-2045(18)30569-2 Barrett, 2019, PI-RADS version 2.1: one small step for prostate MRI, Clin Radiol, 10.1016/j.crad.2019.05.019 Hamoen, 2015, Use of the prostate imaging reporting and data system (PI-RADS) for prostate cancer detection with multiparametric magnetic resonance imaging: a diagnostic meta-analysis, Eur Urol, 67, 1112, 10.1016/j.eururo.2014.10.033 Shariat, 2008, Using biopsy to detect prostate cancer, Rev Urol, 10, 262